Glecaprevir + Pibrentasvir Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Reference Brands: Mavyret (US); Maviret (EU)

Category: Anti Viral

Glecaprevir + Pibrentasvir is available in Tablet and strengths such as Glecaprevir- 100 mg + Pibrentasvir - 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glecaprevir + Pibrentasvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Glecaprevir + Pibrentasvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Mavyret (US) / Maviret (EU) is a fixed-dose combination of Glecaprevir 100 mg and Pibrentasvir 40 mg per tablet, approved by the FDA and EMA for the treatment of chronic hepatitis C virus (HCV) infection across genotypes 1–6. This pan-genotypic regimen is taken as three tablets once daily with food. It offers one of the shortest HCV treatments—just 8 weeks for most patients. Mavyret is highly effective (SVR >95%) and suitable for use in patients with renal impairment and compensated cirrhosis. Its ribavirin-free formulation improves tolerability, making it a convenient, high-efficacy option for diverse patient populations.